1. Christen Y, Waeber B, Nussberger J, Porchet M, Borland RM, Lee RJ, Maggon K, Shum L, Timmermans PBMWM, Brunner HR (1991) Oral administration of DuP 753, a specific angiotensin II receptor anatgonist, to normal male volunteers; inhibition of pressor response to exogenous angiotensin I and II. Circulation 83: 1333–1342
2. Dzau VJ (1990) Mechanism of action of angiotensin — converting inhibitors in hypertension and heart failure. Role of plasma versus tissue ACE. Drugs 39, suppl 2
3. Dzau VJ, Gibbons GH (1991) The role of the endothelium in vascular remodeling. In: Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. Rubanyi GM (ed) New York: Futura Publishing, pp. 281–291
4. Dzau VJ (1988) The tissue renin-angiotensin-system: implications for angiotensin converting enzyme inhibition. Curr. Opinion Cardiol. 3, suppl 1, 97–102
5. Grobecker H, Ploetz H (1992) Effect of ACE-inhibitor quinapril on blood pressure and glucose disposition in diabetic spontaneously hypertensive rats (SHR). J of Hypertension 10, suppl 4, 5100